Sex Differences in Using Systemic Inflammatory Markers to Prognosticate Patients with Head and Neck Squamous Cell Carcinoma
- 1 October 2018
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Cancer Epidemiology, Biomarkers & Prevention
- Vol. 27 (10) , 1176-1185
Abstract
Background: Remarkable discrepancy exists in outcomes between men and women for multiple malignancies. We sought to expose sex differences in using platelet count and neutrophil-to-lymphocyte ratio (NLR) to predict overall survival for select cancer types with focus on head and neck squamous cell carcinoma (HNSCC).Methods: Peripheral blood samples from 9,365 patients seen in a tertiary teaching hospital with nine different primary tumors were retrospectively examined. HNSCC RNA-sequencing data from The Cancer Genome Atlas were analyzed by two computational means [Cell-type Identification By Estimating Relative Subsets Of RNA Transcripts (CIBERSORT) and Estimation of Stromal and Immune cells in Malignant Tumor tissues using Expression data (ESTIMATE)] to extend our observations to the tumor microenvironment.Results: For HNSCC, platelet count was more predictive of overall survival for males [log-rank test: HR = 1.809; 95% confidence interval (CI), 1.461–2.239 vs. HR = 1.287; 95% CI, 0.8901–1.861], whereas NLR was more predictive for females (HR = 2.627; 95% CI, 1.716–4.02 vs. HR = 1.261; 95% CI, 0.998–1.593). For females, lymphocyte count was more associated with survival than neutrophil count (multivariate Cox regression: P = 0.0015 vs. P = 0.7476). Both CIBERSORT (P = 0.0061) and ESTIMATE (P = 0.022) revealed greater immune infiltration in females. High tumor infiltration by T lymphocytes was more strikingly associated with survival in females (HR = 0.20, P = 0.0281) than in males (HR = 0.49, P = 0.0147).Conclusions: This is the first study to comprehensively demonstrate sex bias in the clinical utility of platelet, granulocyte, and lymphocyte counts as biomarkers to prognosticate HNSCC patients.Impact: This work emphasizes the necessity to consider sex in appraising inflammatory markers for cancer risk stratification. Cancer Epidemiol Biomarkers Prev; 27(10); 1176–85. ©2018 AACR.Keywords
Funding Information
- NIH (P01 CA186866, R01 CA213290, R01 CA188419, R01 AI077283)
- NIH (R01 GM122078 and R21 CA209848)
- Hollings Cancer Center's Cancer Center (P30 CA138313)
This publication has 48 references indexed in Scilit:
- Pitfalls and limitations in translation from biomarker discovery to clinical utility in predictive and personalised medicineEPMA Journal, 2013
- TGF-β signalling and its role in cancer progression and metastasisCancer and Metastasis Reviews, 2012
- A new prognostic model for cancer‐specific survival after radical cystectomy including pretreatment thrombocytosis and standard pathological risk factorsBJU International, 2012
- Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 2011
- Female hormonal and reproductive factors and head and neck squamous cell carcinoma riskCancer Letters, 2011
- Bring on the biomarkersNature, 2011
- Tobacco and alcohol use increases the risk of both HPV-associated and HPV-independent head and neck cancersCancer Causes & Control, 2010
- Gender Dependence for a Subset of the Low-Abundance Signaling Proteome in Human PlateletsHuman Genomics and Proteomics, 2010
- Conversion of Peripheral CD4+CD25− Naive T Cells to CD4+CD25+ Regulatory T Cells by TGF-β Induction of Transcription Factor Foxp3 Journal of Experimental Medicine, 2003
- Modeling Survival Data: Extending the Cox ModelTechnometrics, 2002